The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 184 participants.

Also called NCT07167550

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 184 participants (planned count) (from the registry)
Sponsor
Tatchempharmpreparaty, JSC (from the registry)
Registry
  • NCT NCT07167550
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07167550. Randomized; double masking; primary purpose treatment. Start 2025-09-06 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke
Condition
Stroke
Condition
Acute Stroke
Condition
Cerebrovascular Disorders
Condition
Physiological Effects of Drugs
Intervention (Drug)
Dimephosphon®
Intervention (Drug)
Placebo
Lead sponsor
Tatchempharmpreparaty, JSC (class: industry)

Record details

Record id
cardio:ct-nct07167550
Content hash
9cd4b6127a4eeec542bb27d04c8d3288d4af3a50c3ddcfee9e7bdaf4ddcf4d80